{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:45:07Z","timestamp":1794717907550,"version":"4.9.1"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.cco.0000239879.31463.42","type":"journal-article","created":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T08:05:54Z","timestamp":1154937954000},"page":"425-431","source":"Crossref","is-referenced-by-count":51,"title":["Primary cutaneous B-cell lymphoma: classification and treatment"],"prefix":"10.1097","volume":"18","author":[{"given":"Rein","family":"Willemze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphoma: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V99.3.800","article-title":"Primary cutaneous lymphomas: applicability of current classification schemes (EORTC, WHO) based on clinicopathologic features observed in a large group of patients","volume":"99","author":"Pink-Fuches","year":"2002","journal-title":"Blood"},{"key":"R3-4-20210128","article-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2559.1993.tb00469.x","article-title":"Cutaneous immunocytomas: a clinicopathologic study of 26 cases","volume":"23","author":"Rijlaarsdam","year":"1993","journal-title":"Histopathology"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-4362.1990.tb03469.x","article-title":"Clinicopathologic study of cutaneous plasmacytoma","volume":"29","author":"Torne","year":"1990","journal-title":"Int J Dermatol"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00000478-200308000-00003","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases","volume":"27","author":"Li","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features of 50 patients","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"key":"R10-4-20210128","first-page":"480","article-title":"Primary cutaneous marginal zone B-cell lymphoma","volume":"15","author":"Tsuji","year":"2005","journal-title":"Eur J Dermatol"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","article-title":"Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma","volume":"24","author":"Cerroni","year":"1997","journal-title":"J Cutan Pathol"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-200009000-00012","article-title":"Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland","volume":"24","author":"Goodlad","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1034\/j.1600-0560.2001.281002.x","article-title":"Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States","volume":"28","author":"Wood","year":"2001","journal-title":"J Cutan Pathol"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00000372-199210000-00006","article-title":"Evolution of B-cell lymphoma from pseudolymphoma","volume":"14","author":"Sangueza","year":"1992","journal-title":"Am J Dermatopathol"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2230.2004.01692.x","article-title":"Primary cutaneous plasmacytoma: a role for a triggering stimulus?","volume":"30","author":"Zendri","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2005.04.036","article-title":"Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination","volume":"53","author":"May","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000478-200106000-00004","article-title":"Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2002-11-3502","article-title":"Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma","volume":"102","author":"Ye","year":"2003","journal-title":"Blood"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"t(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/path.1711","article-title":"FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma","volume":"205","author":"Schreuder","year":"2005","journal-title":"J Pathol"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2005.04.043","article-title":"Primary cutaneous B-cell lymphoma","volume":"53","author":"Bogle","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2005.01.093","article-title":"Treatment of primary cutaneous B-cell lymphoma with rituximab","volume":"52","author":"Fink-Puches","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1200\/JCO.1999.17.8.2471","article-title":"Treatment of multifocal primary cutaneous B-cell lymphoma: guidelines of the Dutch Cutaneous Lymphoma Group","volume":"17","author":"Bekkenk","year":"1999","journal-title":"J Clin Oncol"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicular center cell lymphoma with follicular growth pattern","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000478-200206000-00006","article-title":"Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity","volume":"26","author":"Goodlad","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00000372-200008000-00001","article-title":"Cutaneous spindle-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma","volume":"22","author":"Cerroni","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.1998.16.6.2080","article-title":"Bcl-2 expression in primary cutaneous large B-cell lymphoma is site-related","volume":"16","author":"Geelen","year":"1998","journal-title":"J Clin Oncol"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/modpathol.3880398","article-title":"Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases","volume":"14","author":"Aguilera","year":"2001","journal-title":"Mod Pathol"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2002.20.3.647","article-title":"Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features","volume":"20","author":"Mirza","year":"2002","journal-title":"J Clin Oncol"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000478-200312000-00006","article-title":"Primary cutaneous diffuse large B-cell lymphoma: prognostic significance and clinicopathologic subtypes","volume":"27","author":"Goodlad","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2003-08-2726","article-title":"Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas","volume":"103","author":"Grange","year":"2004","journal-title":"Blood"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0303-6987.2005.00298.x","article-title":"Expression of bcl-6 and Mum1\/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study","volume":"32","author":"Sundram","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","article-title":"Absence of the t(14, 18) chromosomal translocation in primary cutaneous B-cell lymphoma","volume":"144","author":"Child","year":"2001","journal-title":"Br J Dermatol"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array-based CGH analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman","year":"2006","journal-title":"J Clin Oncol"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1200\/JCO.1996.14.2.549","article-title":"Treatment of primary cutaneous B-cell lymphomas of follicular center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy","volume":"14","author":"Rijlaarsdam","year":"1996","journal-title":"J Clin Oncol"},{"key":"R41-4-20210128","first-page":"49","article-title":"Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma","volume":"13","author":"Piccino","year":"2003","journal-title":"Eur J Dermatol"},{"key":"R42-4-20210128","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1097-0142(20001015)89:8<1835::AID-CNCR26>3.0.CO;2-H","article-title":"Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma","volume":"89","author":"Heinzerling","year":"2000","journal-title":"Cancer"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2133.2005.06659.x","article-title":"Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphoma: an applicational observation","volume":"153","author":"Gellrich","year":"2005","journal-title":"Br J Dermatol"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archderm.1996.03890350042008","article-title":"Primary cutaneous large B-cell lymphomas of the legs: a distinct type of cutaneous B-cell lymphoma with an intermediate prognosis","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6 and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gcc.10104","article-title":"Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis","volume":"35","author":"Mao","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.0022-202X.2003.12635.x","article-title":"Cytogenetic aberration patterns differ in subtypes of primary cutaneous B-cell lymphomas","volume":"122","author":"Hallerman","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R50-4-20210128","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.pas.0000155163.40668.e7","article-title":"Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases","volume":"29","author":"Wiesner","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R51-4-20210128","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0625.2005.00376.x","article-title":"Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas","volume":"14","author":"Gimenez","year":"2005","journal-title":"Exp Dermatol"},{"key":"R52-4-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/S0190-9622(03)00889-2","article-title":"Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a North American series","volume":"49","author":"Brogan","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R53-4-20210128","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2133.2005.06803.x","article-title":"Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma","volume":"153","author":"Gilaberte","year":"2005","journal-title":"Br J Dermatol"},{"key":"R54-4-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0560.1996.tb01282.x","article-title":"T-cell rich B-cell lymphoma presenting in the skin: a clinicopathologic analysis of six cases","volume":"23","author":"Sander","year":"1996","journal-title":"J Cutan Pathol"},{"key":"R55-4-20210128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/modpathol.3880250","article-title":"Primary cutaneous T-cell rich B-cell lymphoma: clinically distinct from its nodal counterpart?","volume":"14","author":"Li","year":"2001","journal-title":"Mod Pathol"},{"key":"R56-4-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-199506000-00005","article-title":"Malignant angioendotheliomatosis is an angiotropic intravascular lymphoma: immunohistochemical, ultrastructural and molecular genetic studies","volume":"17","author":"Perniciaro","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"R57-4-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases with special emphasis on the \u2018cutaneous variant\u2019","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"R58-4-20210128","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/modpathol.3800397","article-title":"Intravascular large B-cell lymphoma involving hemangiomas: an unusual presentation of a rare neoplasm","volume":"18","author":"Nixon","year":"2005","journal-title":"Mod Pathol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.cco.0000239879.31463.42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:15:02Z","timestamp":1620936902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-200609000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.cco.0000239879.31463.42","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}